KVYO.NYSEKlaviyo, INC

Form 4: Klaviyo CFO Sells Shares Under 10b5-1 Plan

Sentiment:

Insider Transaction Report


Klaviyo's Chief Financial Officer, Amanda Whalen, sold 15,000 shares of Series A Common Stock for approximately $375,447 through a pre-arranged trading plan.

Summary

  • Amanda Whalen, Chief Financial Officer of Klaviyo, Inc. (KVYO), reported transactions involving the company's equity securities.
  • On October 10, 2025, Ms. Whalen converted 15,000 shares of Series B Common Stock into 15,000 shares of Series A Common Stock.
  • Immediately following the conversion, she sold a total of 15,000 shares of Series A Common Stock in two separate transactions.
  • The first sale involved 9,808 shares at a weighted average price of $25.33 per share, with prices ranging from $24.93 to $25.85.
  • The second sale involved 5,192 shares at a weighted average price of $24.45 per share, with prices ranging from $24.25 to $24.73.
  • These transactions were executed pursuant to a Rule 10b5-1 trading plan adopted by Ms. Whalen on August 16, 2024.
  • Following these transactions, Ms. Whalen beneficially owns 481,719 shares of Series A Common Stock (including 439,032 unvested RSUs) and 393,476 shares of Series B Common Stock (including 184,375 unvested RSUs).

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While insider selling can sometimes be viewed negatively, the execution under a pre-arranged Rule 10b5-1 plan mitigates concerns, indicating a routine transaction for personal financial management rather than a reflection of company performance.

Positives

  • The transactions were conducted under a Rule 10b5-1 trading plan, indicating pre-scheduled sales for diversification or liquidity rather than a reaction to new, negative information.

Negatives

  • The sale of 15,000 shares by a key executive reduces insider ownership, which can sometimes be perceived as a slight negative by investors, although mitigated by the 10b5-1 plan.

Risks

  • No specific risks were mentioned in this Form 4 filing beyond the general market perception of insider selling.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Management Comments

  • The transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024.

Industry Context

Insider transactions, particularly those executed under Rule 10b5-1 plans, are a common occurrence in publicly traded companies. These plans allow insiders to sell a predetermined number of shares at a predetermined time or price, providing an affirmative defense against insider trading allegations and facilitating executive diversification and liquidity management.

Comparison to Industry Standards

  • The use of a Rule 10b5-1 trading plan for insider stock sales is a standard corporate governance practice across industries, demonstrating a commitment to transparency and compliance with SEC regulations.
  • The volume of shares sold (15,000 shares) by a CFO of a company like Klaviyo is generally considered routine for executive compensation and personal financial planning, and not indicative of a significant shift in company prospects when executed under a pre-arranged plan.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Policy ImplementationThe reporting person executed transactions under a Rule 10b5-1 trading plan, a corporate governance mechanism designed to allow insiders to sell shares without violating insider trading laws.08/16/2024Enhances transparency and provides an affirmative defense against insider trading allegations for pre-scheduled sales, aligning with best practices in corporate governance.

Stakeholder Impact

  • Shareholders: A minor reduction in insider ownership, but the pre-planned nature of the sale under a 10b5-1 plan suggests no immediate negative implications for company fundamentals.
  • Management: The CFO's personal financial planning and diversification are facilitated through the sale of shares.

Next Steps

  • No specific future actions, events, or milestones are mentioned in this Form 4 filing.

Key Dates

DateDescription
08/16/2024Date Rule 10b5-1 trading plan was adopted by the Reporting Person.
10/10/2025Date of reported transactions (conversion of Series B to Series A and subsequent sale of Series A Common Stock).

Recommendation

hold

The reported transactions represent a routine insider sale by the Chief Financial Officer under a pre-arranged Rule 10b5-1 trading plan. Such sales are common for executive compensation and diversification purposes and do not typically signal a change in company fundamentals or warrant a shift in investment thesis. Investors should continue to evaluate Klaviyo based on its operational performance and market position, as this filing provides no new material information to alter a fundamental investment decision.

Keywords

Klaviyo, KVYO, Form 4, Insider Trading, Stock Sale, CFO, Amanda Whalen, 10b5-1 Plan, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.